PART I This Annual Report on Form 10-K (including the section regarding Managements Discussion and Analysis of Financial Condition and Results of Operations) contains forward-looking statements regarding our business, financial condition, results of operations and prospects. All statements contained in this Annual Report other than statements of historical fact, including, but not limited to, statements regarding the launch and commercialization of TONMYA and our migraine products, our future re...
Q2 FY2026 — expected 2026-09-28
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001999371-26-005730 | EDGAR | 117K words |
| 2025-03-18 | 2024-12-31 | 0001999371-25-002786 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001999371-24-004297 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001387131-23-003377 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0001387131-22-003640 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001387131-21-003550 | EDGAR | — |
| 2020-03-24 | 2019-12-31 | 0001387131-20-003189 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001387131-19-001980 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001615774-18-001762 | EDGAR | — |
| 2017-04-13 | 2016-12-31 | 0001615774-17-001665 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001999371-25-017370 | EDGAR | 32K words |
| 2025-08-11 | 2025-06-30 | 0001999371-25-011050 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001999371-25-005875 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001999371-24-014569 | EDGAR | — |
| 2024-08-16 | 2024-06-30 | 0001999371-24-010281 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001999371-24-005989 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001839882-23-030328 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001387131-23-009608 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001387131-23-006175 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001387131-22-011157 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001387131-22-008503 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001387131-22-005860 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001999371-26-007254 | EDGAR | 6K words |
| 2026-03-26 | 0001999371-26-006915 | EDGAR | — |
| 2026-03-18 | 0001999371-26-006169 | EDGAR | — |
| 2026-03-13 | 0001999371-26-005742 | EDGAR | — |
| 2026-03-10 | 0001999371-26-005466 | EDGAR | — |
| 2026-03-03 | 0001999371-26-004897 | EDGAR | — |
| 2026-02-03 | 0001999371-26-002429 | EDGAR | — |
| 2025-12-29 | 0001999371-25-021283 | EDGAR | — |
| 2025-12-29 | 0001999371-25-021194 | EDGAR | — |
| 2025-12-16 | 0001999371-25-020361 | EDGAR | — |
643 total filings indexed. 611 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001430306 |
| Ticker | TNXP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.tonixpharma.com |
| Listed | 2009-02-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report